Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies.
Cellarity has raised $121.0M in total funding. The most recent round was Series C. The last funding was announced in October 2022.
Cellarity's investors include BlackRock, Flagship Pioneering, The Baupost Group, Pictet Private Equity Investors S.A., Hanwha Impact Partners.
Cellarity is headquartered in Somerville, United States.
Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies.
Cellarity is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cellarity — Funding & Investors." VCBacked, October 4, 2022, https://www.vcbacked.co/company/cellarity. Accessed September 30, 2026.
VCBacked. (2022). Cellarity — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/cellarity
{{cite web |title=Cellarity — Funding & Investors |url=https://www.vcbacked.co/company/cellarity |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated